Anthony Nolan

Stem Cell Registry and Research Institute in Cellular Therapies

Anthony Nolan
Stem Cell Registry and Research Institute in Cellular Therapies

In 1974 Shirley Nolan’s son Anthony was born with a rare blood disorder for which treatment options were limited. Learning of a then-experimental treatment which transplanted donated healthy bone marrow into patients living with blood cancer and other blood disorders, Shirley campaigned and fundraised to establish a register of people willing to donate their bone marrow in hope of saving a life. Sadly, Anthony Nolan died in in 1979, aged just seven; his legacy lives on in the charity which carries his name.

Today the stem cell register stands at over 900,000 potential lifesavers, enabling four transplants per day.

Alongside the setting up of the world’s first stem cell registry, Anthon Nolan began investing in research to improve outcomes for patients. In 1993, the Anthony Nolan Research Institute was established, driving ground-breaking research to reduce post-transplant complications and improve survival and quality of life after transplant.
Anthony Nolan currently invests in research into cellular therapies that include stem cell transplants, but also more prospective or novel therapies.

Register Your Interest

Name(Required)